HealthGovernment Caps Trade Margin at 30% to Cut Cancer Drug Prices
The Indian government has capped trade margins at 30% for all non-scheduled anti-cancer drugs, including branded, generic, domestic, imported, patented, and non-patented medicines. This move could reduce cancer drug prices by up to 70%, saving patients around Rs 2,500 crore annually. The decision aims to curb high supply chain mark-ups and make cancer treatment more affordable without affecting drug availability, following Supreme Court intervention on pricing disparities.
DNA India·



